Actinium Pharmaceuticals, Inc.
ATNM
$1.30
$0.1513.04%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 28.66% | 12.87% | 25.22% | 21.45% | 12.43% |
| Total Depreciation and Amortization | 2.51% | 1.00% | -9.57% | 18.68% | 23.60% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 29.77% | 45.17% | 37.26% | 38.77% | -5.31% |
| Change in Net Operating Assets | -171.47% | -288.93% | 454.27% | 94.29% | -59.05% |
| Cash from Operations | 23.22% | -7.64% | 41.57% | 51.09% | 3.70% |
| Capital Expenditure | -- | 100.00% | 100.00% | 85.53% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | 100.00% | 85.53% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -100.00% | -100.00% | -200.00% | -100.00% | 0.00% |
| Issuance of Common Stock | -- | 60.92% | -0.92% | 1,815.69% | -75.62% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.25% | 60.91% | -0.94% | 1,817.92% | -75.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.64% | 11.12% | 154.42% | 151.33% | -117.10% |
